Metal Complex Formation and Anticancer Activity of Cu(I) and Cu(II) Complexes with Metformin

Sherin Abdelrahman, Mawadda Alghrably, Marcello Campagna, Charlotte Armgard Emma Hauser, Mariusz Jaremko, Joanna Izabela Lachowicz

Research output: Contribution to journalArticlepeer-review

Abstract

Metformin has been used for decades in millions of type 2 diabetes mellitus patients. In this time, correlations between metformin use and the occurrence of other disorders have been noted, as well as unpredictable metformin side effects. Diabetes is a significant cancer risk factor, but unexpectedly, metformin-treated diabetic patients have lower cancer incidence. Here, we show that metformin forms stable complexes with copper (II) ions. Both copper(I)/metformin and copper(II)/metformin complexes form adducts with glutathione, the main intracellular antioxidative peptide, found at high levels in cancer cells. Metformin reduces cell number and viability in SW1222 and K562 cells, as well as in K562-200 multidrug-resistant cells. Notably, the antiproliferative effect of metformin is enhanced in the presence of copper ions.
Original languageEnglish (US)
Pages (from-to)4730
JournalMolecules
Volume26
Issue number16
DOIs
StatePublished - Aug 5 2021

ASJC Scopus subject areas

  • Organic Chemistry

Fingerprint

Dive into the research topics of 'Metal Complex Formation and Anticancer Activity of Cu(I) and Cu(II) Complexes with Metformin'. Together they form a unique fingerprint.

Cite this